Loading...

HLS Therapeutics Inc.

HLTRF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$3.21
$0.00(0.00%)
U.S. Market opens in 14h 21m

HLS Therapeutics Inc. (HLTRF) Stock Overview

Explore HLS Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap100.4M
P/E Ratio-8.06
EPS (TTM)$-0.39
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$2.70
3 Months$3.13
1 Year Target$4.27

HLTRF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HLS Therapeutics Inc. (HLTRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.06 and a market capitalization of 100.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
2.56%
1-Month Change
-4.46%
3-Month Change
-4.46%
6-Month Change
-20.15%
Year-to-Date (YTD) Change
-6.41%
1-Year Change
8.45%
3-Year Change
-31.05%
5-Year Change
-81.10%
All-Time (Max) Change
671.63%

Contact Information

https://www.hlstherapeutics.com
+1 416 679 0599
10 Carlson Court, Etobicoke, ON, M9W 6L2

Company Facts

92 Employees
IPO DateJan 27, 2010
CountryCA
Actively Trading

Frequently Asked Questions